GlassScriptPhysician profile
Gregory A Stynowick
NPI 1437256542
$14,056.32
in general payments reported to CMS, 2019-2025
48 companies · $1,695 in 2025
The $1,695 reported for 2025 was more than what 76% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,285 · 2020: $1,372 · 2021: $1,733 · 2022: $2,417 · 2023: $1,731 · 2024: $1,823 · 2025: $1,695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,157 · Travel and Lodging: $1,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,156.54 |
| Travel and Lodging | $1,092.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $2,200.98 | 2022-2025 | Ha Minuteman G3-R |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $2,121.24 | 2019-2025 | Relistor, Trulance |
| Vertiflex, INC. | $2,002.03 | 2019 | |
| Boston Scientific Corporation | $1,592.00 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Curonix LLC | $740.86 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $520.11 | 2021-2025 | Ubrelvy |
| Nevro Corp. | $417.95 | 2019-2024 | Senza |
| Collegium Pharmaceutical, INC. | $388.87 | 2019-2024 | Belbuca, Xtampza |
| Stimwave Technologies Incorporated | $318.43 | 2019-2021 | |
| Abbott Laboratories | $317.40 | 2019-2024 | Proclaim, Eterna |
| Ibsa Pharma INC. | $295.96 | 2022-2025 | Licart, Tirosint, Flector |
| Biotronik Nro, INC. | $269.58 | 2023-2025 | Prospera, Biotronik |
| Biodelivery Sciences International, INC. | $267.63 | 2019-2021 | |
| Vertos Medical, INC. | $266.76 | 2023 | Mild Device Kit |
| Amgen INC. | $250.16 | 2020-2022 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Stynowick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.